Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProDiuS: Protocolized Diuretic Strategy in Cardiorenal Failure
NCT01921829Phase 4Terminated
- Start
- Nov 2013
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide, metolazone, chlorothiazide in cardiorenal syndrome (CRS). Started Nov 2013; status: terminated.
02
Drugs
furosemidemetolazonechlorothiazide
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT01921829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921829.